Related Experiment Video
Updated: May 4, 2026
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
Deferiprone: structural and functional modulating agent of hemoglobin fructation.
Naghmeh Sattarahmady1, Hossein Heli, Ali A Moosavi-Movahedi
1Department of Medical Physics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, sattarahmady@yahoo.com.
Deferiprone, an iron chelator, prevents advanced glycation end product (AGE) formation by inhibiting structural changes in hemoglobin during fructation. This suggests deferiprone
Area of Science:
- Biochemistry
- Pharmacology
- Diabetology
Background:
- Diabetic complications are linked to advanced glycation end products (AGEs).
- Identifying anti-glycation compounds is crucial for managing diabetes.
- Hemoglobin fructation is a marker of glycation.
Purpose of the Study:
- To investigate the anti-glycation effects of deferiprone.
- To assess deferiprone's impact on hemoglobin fructation.
- To explore deferiprone's potential as an AGE inhibitor.
Main Methods:
- Studied the effect of deferiprone on hemoglobin (Hb) fructation.
- Assessed AGE and carbonyl formation in Hb.
- Evaluated the preservation of Hb enzymatic activities (peroxidase, esterase).
Main Results:
- Deferiprone inhibited AGE and carbonyl formation during Hb fructation.
- Deferiprone prevented structural changes in Hb.
- Deferiprone preserved the peroxidase and esterase activities of fructated Hb.
Conclusions:
- Deferiprone exhibits anti-glycation properties.
- Deferiprone can be a potential therapeutic agent to prevent AGE formation.
- Deferiprone may help mitigate diabetic complications associated with AGEs.
More Related Videos
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Related Concept Videos
01:29Structure and Function of Erythrocytes
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:24Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:19Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
01:21Hematopoiesis
01:01Regulation of Hematopoietic Stem Cells